» Articles » PMID: 31728643

Development and Characterization of a Suturable Biomimetic Patch for Cardiac Applications

Overview
Publisher Springer
Date 2019 Nov 16
PMID 31728643
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

3D scaffolds used to repair damaged tissues should be able to mimic both composition and functions of natural extracellular matrix, which is mainly composed of polysaccharides and proteins. In our previous research new biomimetic sponges, based on blends of alginate with gelatin, were produced and characterized for myocardial tissue engineering applications. It was observed that these scaffolds can potentially function as a promising cardiac extracellular matrix substitute, but a reinforcement is required to improve their suturing properties. Aim of the present work was the development of a suturable biomimetic patch by the inclusion of a synthetic mesh within an alginate/gelatin scaffold. The mesh, produced by dry spinning, was made of eight superimposed layers of polycaprolactone microfibers, each one rotated of 45° with respect to the adjacent one. Reinforced scaffolds were obtained through the use of a mold, specially designed to place the fibrous mesh exactly in the center of the sponge. Both the reinforcement mesh and the reinforced scaffold were characterized. A perfect integration between the mesh and the sponge was observed. The fibrous mesh reduced the capacity of the sponge to absorb water, but the degree of hydrophilicity of the material was still comparable with that of natural cardiac tissue. The reinforced system showed a suitable stability in aqueous environment and it resulted much more resistant to suturing than not reinforced scaffold and even than human arteries. Polycaprolactone mesh was not cytotoxic and the reinforced scaffold was able to support cardiomyocytes adhesion and proliferation. Overall, the obtained results confirmed that the choice to modify the alginate/gelatin sponges through the insertion of an appropriate reinforcement system turned out to be correct in view of their potential use in myocardial tissue engineering.

Citing Articles

Biomaterials for Regenerative Medicine in Italy: Brief State of the Art of the Principal Research Centers.

Camponogara F, Zanotti F, Trentini M, Tiengo E, Zanolla I, Pishavar E Int J Mol Sci. 2022; 23(15).

PMID: 35897825 PMC: 9368060. DOI: 10.3390/ijms23158245.


Polymeric Biomaterials for the Treatment of Cardiac Post-Infarction Injuries.

Trombino S, Curcio F, Cassano R, Curcio M, Cirillo G, Iemma F Pharmaceutics. 2021; 13(7).

PMID: 34371729 PMC: 8309168. DOI: 10.3390/pharmaceutics13071038.


Preparation and characterization of gelatin-polysaccharide composite hydrogels for tissue engineering.

Ye J, Yang G, Zhang J, Xiao Z, He L, Zhang H PeerJ. 2021; 9:e11022.

PMID: 33777525 PMC: 7971083. DOI: 10.7717/peerj.11022.

References
1.
Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash I, Battler A . Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium?. Circulation. 2000; 102(19 Suppl 3):III56-61. DOI: 10.1161/01.cir.102.suppl_3.iii-56. View

2.
Chen Z, Wang P, Wei B, Mo X, Cui F . Electrospun collagen-chitosan nanofiber: a biomimetic extracellular matrix for endothelial cell and smooth muscle cell. Acta Biomater. 2009; 6(2):372-82. DOI: 10.1016/j.actbio.2009.07.024. View

3.
Jawad H, Ali N, Lyon A, Chen Q, Harding S, Boccaccini A . Myocardial tissue engineering: a review. J Tissue Eng Regen Med. 2007; 1(5):327-42. DOI: 10.1002/term.46. View

4.
Hu M, Kurisawa M, Deng R, Teo C, Schumacher A, Thong Y . Cell immobilization in gelatin-hydroxyphenylpropionic acid hydrogel fibers. Biomaterials. 2009; 30(21):3523-31. DOI: 10.1016/j.biomaterials.2009.03.004. View

5.
Barbani N, Guerra G, Cristallini C, Urciuoli P, Avvisati R, Sala A . Hydroxyapatite/gelatin/gellan sponges as nanocomposite scaffolds for bone reconstruction. J Mater Sci Mater Med. 2011; 23(1):51-61. DOI: 10.1007/s10856-011-4505-2. View